|1.||Suzuki, Kazuyuki: 2 articles (09/2011 - 09/2005)|
|2.||Kudara, Norihiko: 2 articles (09/2011 - 09/2005)|
|3.||Chiba, Toshimi: 2 articles (09/2011 - 09/2005)|
|4.||Abiko, Yukito: 2 articles (09/2011 - 09/2005)|
|5.||Hattori, Takamichi: 2 articles (08/2007 - 08/2006)|
|6.||Uchiyama, Tomoyuki: 2 articles (08/2007 - 08/2006)|
|7.||Sakakibara, Ryuji: 2 articles (08/2007 - 08/2006)|
|8.||Yamaguchi, Taketo: 2 articles (08/2007 - 08/2006)|
|9.||Ito, Takashi: 2 articles (08/2007 - 08/2006)|
|10.||Odaka, Takeo: 2 articles (08/2007 - 08/2006)|
08/01/2006 - "Polycarbophil may be useful for the treatment of constipation."
08/01/1998 - "The study aims were to: (i) investigate the composition of the intestinal ecosystem in chronic functional constipation; (ii) establish whether the addition of the water-holding agent calcium polycarbophil to the diet induces an improvement in constipation; and (iii) determine the composition of the intestinal ecosystem after the use of this agent. "
08/01/1998 - "Twenty-eight children with functional chronic constipation without anatomical disorders were treated double-blind in random sequence for 1 month with an oral preparation of calcium polycarbophil (0.62 g/twice daily) or placebo. "
02/01/1993 - "Statistically significant differences favouring polycarbophil were found among the following patient subgroups: 15 (79%) of 19 with constipation: all six with alternating diarrhoea and constipation; 13 (87%) of 15 with bloating: and 11 (92%) of 12 with two or more symptoms. "
08/15/2007 - "Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects."
09/01/2011 - "Decreases in serum high sensitive CRP levels following calcium polycarbophil treatment may be involved in the relief of abdominal symptoms in IBS patients; diarrhea type IBS is characterized by increased MCP-1 expression."
06/01/2002 - "Polycarbophil (500 mg/kg) and CMC increased fecal weight without diarrhea. "
06/01/2002 - "In naive rats, polycarbophil (500 mg/kg) increased fecal weight and water contents without producing diarrhea. "
09/01/1993 - "Hence, the high therapeutic index of Calcium-Polycarbophil makes it highly desirable in the treatment of diarrhea."
09/01/1993 - "[Clinical evaluation of calcium-polycarbophil in the treatment of non-specific diarrhea]."
|3.||Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
02/01/1993 - "At study end, among patients expressing a preference, 15 of 21 (71%) chose polycarbophil over placebo for relief of the symptoms of irritable bowel syndrome. "
09/01/2011 - "Calcium polycarbophil improves abdominal symptoms in patients with irritable bowel syndrome (IBS). "
09/01/2011 - "Serial changes in cytokine expression in irritable bowel syndrome patients following treatment with calcium polycarbophil."
09/01/2005 - "Calcium polycarbophil improves abdominal symptoms in patients with irritable bowel syndrome (IBS). "
02/01/1993 - "Calcium polycarbophil was compared with placebo in 23 patients with irritable bowel syndrome in a six-month, randomized double-blind crossover study. "
02/01/2008 - "In this study, an oral paclitaxel formulation based on thiolated polycarbophil was evaluated in vivo in wild-type rats and in mammary cancer-induced rats. "
02/01/2008 - "It was demonstrated that (1) co-administration of thiolated polycarbophil significantly improved paclitaxel plasma levels, (2) a more constant pharmacokinetic profile could be achieved and (3) the tumor growth was reduced. "
01/01/2012 - "The manuscript presents the critical issues of 5-FU associate with cancer and surpasses issues by engineering novel 5-FU matrix tablets utilizing chitosan- polycarbophil interpolyelectrolyte complex (IPEC). "
|5.||Parkinson Disease (Parkinson's Disease)
|10.||Sodium Salicylate (Salicylate, Sodium)
|1.||Colonic Pouches (S Pouch)